Source: Fluidigm Corporation
Friday, February 05, 2010
Fluidigm, the inventor of integrated fluidic
circuits (IFCs), has joined with IntegraGen SA, one of France's leading
providers of genetic research testing services, to bring IFC technology to
European researchers. IntegraGen will offer premium class services to its
customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access
Array™ sample preparation system for next-generation sequencing. IntegraGen's
lab will also be a demonstration site for European researchers investigating
Fluidigm's technology.
advertisement
Fluidigm instrumentation, combined with its
microfluidic-based chips, provide high-performance, high throughput gene
expression, genotyping, digital PCR, and sample preparation for next-generation
sequencing.
"With this wonderful partnership, researchers will be able to
immediately utilise IntegraGen's premiere services based on Fluidigm technology
and enjoy the benefits of integrated fluidic circuits. In addition, Fluidigm
will have a demonstration site for our European customers to observe and
understand the easy workflow and other unique capabilities of our technology,"
said Dominique Remy-Renou, Fluidigm's Vice President of European Sales and
Support.
"IntegraGen is proud to be able to provide Fluidigm's
technology to its customers. These tools complete the IntegraGen Services
portfolio and put our lab at the cutting edge of genotyping and next generation
sequencing capabilities," said Emmanuel Martin, director of genomic services at
IntegraGen.
Fluidigm develops, manufactures and markets proprietary
Integrated Fluidic Circuit (IFC) systems that significantly improve productivity
in life science research. Fluidigm's IFCs enable the simultaneous performance of
thousands of sophisticated biochemical measurements in extremely minute volumes.
These "integrated circuits for biology" are made possible by miniaturising and
integrating liquid handling components on a single microfluidic device (IFC).
Fluidigm's systems, consisting of instrumentation, software and single-use
chips, increase throughput, decrease costs and enhance sensitivity compared to
conventional laboratory systems. Fluidigm products are only available for
research use. For more information, please visit
www.fluidigm.com.
IntegraGen is dedicated to gene discovery and the commercialization of
molecular diagnostics products and services that provide clinicians with new
tools to personalize diagnosis, treatment, and therapy. IntegraGen is focused on
the prevention and proactive management of complex debilitating diseases, and
dedicated to addressing the needs of patients, clinicians, and advocacy groups.
With discovery and intellectual property focused on diabetes, obesity, bipolar
disorders, schizophrenia, and autism, IntegraGen's Core Strategy is to deliver a
portfolio of high-value molecular diagnostic products and services that drive
personalized healthcare solutions for complex diseases. The Genetic Services
Business provides Genotyping Services to the research community. For more
information, please visit
www.integragen.com.
* Fluidigm, the Fluidigm logo, Topaz,
BioMark, Dynamic Array, Digital Array, Access Array and NanoFlex are trademarks
or registered trademarks of Fluidigm Corporation. All other trademarks are the
property of their respective owners.
---------------------
European
Headquarters
Fluidigm Europe B.V
Parnassustoren, Locatellikade 1
1076 AZ
Amsterdam
Netherlands.
Technical Contact: Leila Smith
Media Contact: Dr Bill
Bradbury
tel. +33-44-259-3861 (Technical) /
+44-208-546-0869 (Media)
email
leila.smith@fluidigm.com / info@primetek-solutions.com
Worldwide Headquarters
Fluidigm Corporation
7000 Shoreline Court
Suite 100, South San Francisco
CA 94080
USA